Loading company…
SciBen develops antibody preparations, lentivirus products, and related life sciences services.
Founded in 2022 and based in Hefei, China, SciBen develops antibody products using its ShGE gene silencing platform. Its offerings include monoclonal antibodies, lentivirus, cell tissue lysates, and chemiluminescent kits, as well as custom antibody verification and lentivirus construction. The company has an R&D and production base covering 2400 square meters and has worked with Tsinghua University, NIH Infectious Disease Research Institute, and China CDC. It closed an angel round in May 2024 to develop product libraries and advance R&D and commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in